We found that the breast cancer samples had a higher frequency of ECRG4 promoter methylation than paired non-tumor tissues, and promoter region methylation status had a negative correlation with ECRG4 mRNA expression level, which was consistent with previous study [15]. The gene discussed is ECRG4; the disease is breast carcinoma.